Feedback
OncLive®
AJMC®
Pharmacy Times®
Specialty Pharmacy Times

Editorial

Dan Steiber, RPh, Specialty Pharmacy Times Editor-in-Chief
Welcome to our third annual special Oncology edition of Specialty Pharmacy Times! While new targeted oral medications are convenient and effective, they are also expensive and toxic, so the need for creating the greatest effectiveness from therapy is warranted. That's where specialty pharmacy comes in.
Dan Steiber, RPh, Specialty Pharmacy Times Editor-in-Chief
Is it time to take sides or stay on the sidelines? With major happenings in specialty pharmacy, specialty pharmacists will want to take note as the profession moves on.
Dan Steiber, RPh, Specialty Pharmacy Times Editor-in-Chief
Collaborations between manufacturers, specialty pharmacies, and patients must be based on integrity and trust to be successful.
Dan Steiber, RPh, Specialty Pharmacy Times Editor-in-Chief
Dan Steiber, RPh, Specialty Pharmacy Times Editor-in-Chief
Dan Steiber, RPh, Specialty Pharmacy Times Editor-in-Chief
Specialty pharmacy has come a long way, starting with deep community roots. Those deep roots are part of the new trends in expanding specialty to the retail setting, which beings high-tech service and total commitment to patient well-being back to the community.
Dan Steiber, RPh
As industry invests billions into self-administered oncolytics, specialty pharmacy steps in. This special issue focuses on the cutting-edge, real-world practices and successes of specialty pharmacy in oncology.
Dan Steiber, RPh
As the population ages, the care of seniors is expanding and specialty pharmacists will play a more active role in patient management and collaboration with other health care providers.
Dan Steiber, RPh
Dan Steiber, RPh
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2012
Intellisphere, LLC. All Rights Reserved.